loadpatents
name:-0.0075938701629639
name:-0.0053839683532715
name:-0.0035581588745117
CHO; Seok-Goo Patent Filings

CHO; Seok-Goo

Patent Applications and Registrations

Patent applications and USPTO patent grants for CHO; Seok-Goo.The latest application filed is for "composition for preventing or treating graft-versus-host disease comprising tlr5 agonist derived from flagellin as effective component".

Company Profile
2.4.7
  • CHO; Seok-Goo - Seoul KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Composition For Preventing Or Treating Graft-versus-host Disease Comprising Tlr5 Agonist Derived From Flagellin As Effective Component
App 20220218786 - CHO; Seok-Goo ;   et al.
2022-07-14
Cell therapy composition for preventing or treating immune disease comprising mesenchymal stem cells and immunoregulatory t-cells as active ingredient
Grant 10,792,309 - Cho , et al. October 6, 2
2020-10-06
Composition for preventing or treating mucositis comprising NecroX as effective ingredient
Grant 10,272,092 - Cho , et al.
2019-04-30
Composition for preventing or treating B-cell lymphoma comprising IL-21 expressing mesenchymal stem cells
Grant 10,155,024 - Cho , et al. Dec
2018-12-18
Method for Enrichment and Expansion of Virus Antigen-Specific T Cells
App 20180305665 - CHO; Seok Goo ;   et al.
2018-10-25
Pharmaceutical composition for inhibiting immune response through inducing differentiation into regulator T cells and promoting proliferation of regulator T cells
Grant 9,867,832 - Cho , et al. January 16, 2
2018-01-16
Composition For Preventing Or Treating Mucositis Comprising Necrox As Effective Ingredient
App 20170319592 - CHO; SEOK GOO ;   et al.
2017-11-09
Cell Therapy Composition For Preventing Or Treating Immune Disease Comprising Mesenchymal Stem Cells And Immunoregulatory T-cells As Active Ingredient
App 20170239295 - Cho; Mi La ;   et al.
2017-08-24
Pharmaceutical Composition For Inhibiting Immune Response Through Inducing Differentiation Into Regulator T Cells And Promoting Proliferation Of Regulator T Cells
App 20160051558 - CHO; Seok Goo ;   et al.
2016-02-25
Composition For Preventing Or Treating B-cell Lymphoma Comprising Il-21 Expressing Mesenchymal Stem Cells
App 20160008435 - CHO; Seok Goo ;   et al.
2016-01-14
Mesenchymal Stem Cell Incorporating A Nucleotide Sequence Coding Tgfb, And Uses Thereof
App 20120207725 - Cho; Seok Goo ;   et al.
2012-08-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed